New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, April 29, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: ...

It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

People live on average a little over two years after an mCRPC diagnosis. Find statistics here and learn how treatment ...

A global research team has discovered a breakthrough set of urine biomarkers for prostate cancer that outperform the ...

In Anchorage, Providence Alaska Medical Center has become the first facility in the state to offer an innovative treatment ...

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

"It is very reassuring," said study author Recinda Sherman, PhD, MPH, of the North American Association of Central Cancer ...

Overall cancer mortality rates decreased for men, women and children in the U.S. between 2018 and 2022, according to the National Cancer Institute’s “Annual Report to the Nation on the Status of ...

Bayer will present new data from the ARANOTE trial evaluating ultra-low prostate-specific antigen responses with NUBEQA ® ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

Active chemicals in cannabis may help destroy and prevent the growth of prostate cancer cells, according to laboratory and animal studies. However, more research is necessary to determine the ...

Leg pain with prostate cancer may be a sign that cancer has spread to other parts of the body. Prostate cancer may cause leg pain if the disease spreads to the lymph nodes around the groin or bones.